Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Venous Thromboembolism After Knee Arthroplasty”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableStudy completedNCT00846807
What this trial is testing

Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery

Who this might be right for
Arthroplasty, ReplacementThromboembolism
Boehringer Ingelheim 5,476
Large-scale testing (Phase 3)Looking for participantsNCT07213778
What this trial is testing

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Who this might be right for
Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 2,000
Testing effectiveness (Phase 2)Study completedNCT00402467
What this trial is testing

An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Who this might be right for
Venous Thromboembolism
Bayer 613
Testing effectiveness (Phase 2)Study completedNCT00306254
What this trial is testing

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Who this might be right for
Venous Thrombosis
Pfizer 1,225
Not applicableEnded earlyNCT00967447
What this trial is testing

Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

Who this might be right for
ThromboembolismArthroplasty, Replacement, Hip
Boehringer Ingelheim 2
Not applicableStudy completedNCT01557725
What this trial is testing

Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty.

Who this might be right for
Thromboembolic EventsPost-operative Bleeding
Rigshospitalet, Denmark 4,924
Post-approval studies (Phase 4)WithdrawnNCT02054936
What this trial is testing

Evaluation of Wound Drainage After Knee or Hip Arthroplasty

Who this might be right for
Complications; Arthroplasty
University of Michigan
Testing effectiveness (Phase 2)Study completedNCT05752461
What this trial is testing

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Who this might be right for
Prevention of Venous Thromboembolism After Knee Arthroplasty
Beijing Suncadia Pharmaceuticals Co., Ltd 353
Testing effectiveness (Phase 2)Study completedNCT00074828
What this trial is testing

New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery

Who this might be right for
Total Knee ReplacementTotal Hip Replacement
Eli Lilly and Company 511
Testing effectiveness (Phase 2)Study completedNCT04031859
What this trial is testing

Risk Stratification Procedure for Thromboembolism Prophylaxis

Who this might be right for
Total Knee Replacement Surgeries
Ministry of Health, Saudi Arabia 242
Testing effectiveness (Phase 2)Study completedNCT00793234
What this trial is testing

Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery

Who this might be right for
Total Knee Replacement Surgery
ThromboGenics 316
Testing effectiveness (Phase 2)WithdrawnNCT00541320
What this trial is testing

Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)

Who this might be right for
Venous Thromboembolism
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT01203072
What this trial is testing

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisTotal Knee Arthroplasty
Daiichi Sankyo Co., Ltd. 523
Testing effectiveness (Phase 2)Study completedNCT00244725
What this trial is testing

Odiparcil For The Prevention Of Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisFibrillation, AtrialVenous Thromboembolism+1 more
GlaxoSmithKline 961
Large-scale testing (Phase 3)Study completedNCT00152971
What this trial is testing

Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement

Who this might be right for
Arthroplasty, Replacement, KneeThromboembolism
Boehringer Ingelheim 2,615
Testing effectiveness (Phase 2)Looking for participantsNCT06963320
What this trial is testing

Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty

Who this might be right for
Circulatory Disease
Livzon Pharmaceutical Group Inc. 320
Large-scale testing (Phase 3)Study completedNCT01094886
What this trial is testing

Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement

Who this might be right for
ArthritisOsteoarthritis, KneeOsteoarthritis, Hip+1 more
Ortho-McNeil Janssen Scientific Affairs, LLC 56
Post-approval studies (Phase 4)Study completedNCT02810704
What this trial is testing

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

Who this might be right for
Pulmonary EmbolismVenous Thrombosis
Dartmouth-Hitchcock Medical Center 18,883
Not applicableEnded earlyNCT01153698
What this trial is testing

Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

Who this might be right for
Venous ThromboembolismArthroplasty, Replacement
Boehringer Ingelheim 167
Testing effectiveness (Phase 2)Study completedNCT02271399
What this trial is testing

Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Hanyang University Seoul Hospital 156
Next Page